ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 232 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2021. The put-call ratio across all filers is 8.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,832 | -39.0% | 81 | -25.7% | 0.00% | – |
| Q1 2022 | $7,916 | -3.0% | 109 | +12.4% | 0.00% | – |
| Q4 2021 | $8,157 | +17.5% | 97 | +26.0% | 0.00% | – |
| Q3 2021 | $6,945 | +4.0% | 77 | +10.0% | 0.00% | – |
| Q2 2021 | $6,675 | -11.2% | 70 | +6.1% | 0.00% | – |
| Q1 2021 | $7,515 | +59.7% | 66 | +94.1% | 0.00% | – |
| Q4 2020 | $4,707 | +84.7% | 34 | +9.7% | 0.00% | – |
| Q3 2020 | $2,548 | -87.4% | 31 | -93.4% | 0.00% | -100.0% |
| Q3 2019 | $20,192 | -31.3% | 472 | +1.9% | 0.00% | 0.0% |
| Q2 2019 | $29,401 | -6.2% | 463 | +2.4% | 0.00% | -33.3% |
| Q1 2019 | $31,351 | +54.1% | 452 | -3.4% | 0.00% | 0.0% |
| Q4 2018 | $20,349 | – | 468 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |